Baseline Effectiveness Cohort

BEHAVIORAL3 trials

Sponsors

Viz.ai, Inc., Insud Pharma

Conditions

Hypertrophic CardiomyopathySoil-Transmitted HelminthsStroke, Ischemic

Phase 3

Real World Evaluation of an Albendazole-Ivermectin Coformulation Safety and Effectiveness

RecruitingNCT06282315

Insud PharmaSoil-Transmitted Helminths

Start: 2025-09-01End: 2027-02-28Target: 20000Updated: 2025-09-15

Unknown Phase

SYNCHRONISE: LVO Triage Timing and Outcome Study

CompletedNCT04608617

Viz.ai, Inc.Stroke, Ischemic

Start: 2021-03-09End: 2023-04-26Updated: 2024-09-19

Viz HCM (ECG Assist) Utilization Workflow Pilot

CompletedNCT06600256

Viz.ai, Inc.Hypertrophic Cardiomyopathy

Start: 2022-01-10End: 2024-06-30Updated: 2024-09-19